Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
39 hedge funds and large institutions have $23.4M invested in Checkpoint Therapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 23 closing their positions.
667% more call options, than puts
Call options by funds: $391K | Put options by funds: $51K
85% more capital invested
Capital invested by funds: $12.6M → $23.4M (+$10.8M)
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
20.87% more ownership
Funds ownership: 1.33% → 22.2% (+21%)
32% less funds holding
Funds holding: 57 → 39 (-18)
65% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$4.98M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.45M |
| 3 |
TC
TwinBeech Capital
Purchase,
New York
|
+$815K |
| 4 |
PAS
Park Avenue Securities
New York
|
+$256K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$256K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$917K |
| 2 |
Renaissance Technologies
New York
|
-$372K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$364K |
| 4 |
Millennium Management
New York
|
-$132K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$86K |
CKPT Hedge Fund Activity: Q4 2022 in Review
39 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q4 2022, worth a combined $23.4M — up 85% from $12.6M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of CKPT and 8 opened new positions — a net loss of 15 holders — while 10 trimmed existing stakes and 16 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $4.98M. The largest seller was Baader Bank Aktiengesellschaft, exiting entirely with an estimated $917K sold.
- 39 institutional investors held Checkpoint Therapeutics (CKPT) as of Q4 2022, down from 57 in Q3 2022.
- Funds reported $23.4M of Checkpoint Therapeutics stock for Q4 2022, up 85% quarter-over-quarter.
- 8 funds opened new Checkpoint Therapeutics positions in Q4 2022 and 23 closed out, a net change of -15 holders.
- The largest Checkpoint Therapeutics buyer in Q4 2022 was Armistice Capital, an estimated $4.98M added.
- The largest Checkpoint Therapeutics seller in Q4 2022 was Baader Bank Aktiengesellschaft, an estimated $917K sold.
Based on aggregated 13F filings for Q4 2022.